Terpenoid ID | TKC056482 | |
Cell line | 16 | |
Protein target | 15 | |
DiseaseNCIT | 16 | |
ORDO | 3 | |
ICD | 66 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC056482 | J774 | J-774 | 13100 | nM | IC50 | C134780 | |
TKC056482 | A549 | None | 15500 | nM | EC50 | C3512 | |
TKC056482 | HeLa | HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri | 10000 | nM | IC50 | C27677 | |
TKC056482 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 10000 | nM | IC50 | C7978 | |
TKC056482 | BGC-823 | BGC823 | 10000 | nM | IC50 | C27677 | |
TKC056482 | B16 | B-16; B16 melanoma; B16 subline B78; B78 | 3100 | nM | IC50 | C21790 | |
TKC056482 | HT-29 | HT 29; HT29 | 10600 | nM | EC50 | C4349 | |
TKC056482 | ASPC1 | AsPc-1; Aspc-1; ASPC-1; As-PC1; ASPC1; AsPC1; Aspc1; AsPc1 | 12600 | nM | IC50 | C9120 | |
TKC056482 | PANC-1 | Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P | 14900 | nM | IC50 | C9120 | |
TKC056482 | MIA PaCa-2 | MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MIAPACA-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2; MiaPaCa | 10400 | nM | IC50 | C9120 | |
TKC056482 | THP-1 | THP1; THP 1; THPI; THP-1(ATCC); THP-1-O; O-THP-1; Tohoku Hospital Pediatrics-1 | 9100 | nM | IC50 | C9163 | Orphanet_514 |
TKC056482 | 8505C | 8505c | 13500 | nM | EC50 | C3878 | Orphanet_142 |
TKC056482 | FaDu | FaDU; FADU | 14200 | nM | EC50 | C4043 | Orphanet_494547 |
TKC056482 | NCI-N87 | NCI N87; N87; N-87; NCI-H87; H87; H-87; NCIN87 | 4200 | nM | IC50 | C5473 | |
TKC056482 | Lu1 | Lu1 | 11500 | nM | IC50 | C21678 | |
TKC056482 | 518A2 | 518.A2 | 14700 | nM | EC50 | C3224 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC056482 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 29093 | nM | Potency |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 2300 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 4500 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 4000 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3500 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3400 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3080 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 15500 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 5200 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 2500 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3100 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3600 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3400 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 5400 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 5200 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 4120 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 15500 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3600 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 5460 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3600 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3100 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3600 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3080 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3900 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3800 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3600 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3100 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3600 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3080 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 2750 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 4120 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 22200 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3100 | nM | IC50 |
TKC056482 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 3200 | nM | IC50 |
TKC056482 | P17706 | Tyrosine-protein phosphatase non-receptor type 2 | PTPN2 | 2400 | nM | IC50 |
TKC056482 | P17706 | Tyrosine-protein phosphatase non-receptor type 2 | PTPN2 | 3330 | nM | IC50 |
TKC056482 | P17706 | Tyrosine-protein phosphatase non-receptor type 2 | PTPN2 | 6700 | nM | IC50 |
TKC056482 | P23219 | Prostaglandin G/H synthase 1 | PTGS1 | 210000 | nM | IC50 |
TKC056482 | Q72874 | Protease | pol | 8000 | nM | IC50 |
TKC056482 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 11482 | nM | IC50 |
TKC056482 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 15849 | nM | IC50 |
TKC056482 | O43451 | Maltase-glucoamylase, intestinal | MGAM | 0 | Ki | |
TKC056482 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | IDH1 | 102 | % | Activity |
TKC056482 | Q77YF9 | Protein Vpr | vpr | 5623 | nM | Potency |
TKC056482 | P19838 | Nuclear factor NF-kappa-B p105 subunit | NFKB1 | 0 | Activity | |
TKC056482 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 44668 | nM | Potency |
TKC056482 | Q04206 | Transcription factor p65 | RELA | 31 | nM | IC50 |
TKC056482 | Q04206 | Transcription factor p65 | RELA | 31 | nM | IC50 |
TKC056482 | P11511 | Aromatase | CYP19A1 | 32000 | nM | IC50 |
TKC056482 | P11597 | Cholesteryl ester transfer protein | CETP | 46600 | nM | IC50 |
TKC056482 | O42275 | Acetylcholinesterase | ache | 17 | % | Inhibition |
TKC056482 | P08246 | Neutrophil elastase | ELANE | 416 | nM | IC50 |
TKC056482 | P0DTD1 | Replicase polyprotein 1ab | rep | 12 | % | Inhibition |
TKC056482 | P23739 | Sucrase-isomaltase, intestinal | Si | >32 | % | Inhibition |
TKC056482 | P35354 | Prostaglandin G/H synthase 2 | PTGS2 | 40000 | nM | IC50 |
TKC056482 | P35354 | Prostaglandin G/H synthase 2 | PTGS2 | 86000 | nM | IC50 |
TKC056482 | P35354 | Prostaglandin G/H synthase 2 | PTGS2 | 130000 | nM | IC50 |
TKC056482 | P81908 | Cholinesterase | BCHE | 5 | % | Inhibition |
TKC056482 | P83916 | Chromobox protein homolog 1 | CBX1 | 89125 | nM | Potency |
TKC056482 | O00255 | Menin | MEN1 | 19953 | nM | Potency |
TKC056482 | O15296 | Polyunsaturated fatty acid lipoxygenase ALOX15B | ALOX15B | >64 | % | Activity |
TKC056482 | P46063 | ATP-dependent DNA helicase Q1 | RECQL | 159 | nM | Potency |
TKC056482 | Q92830 | Histone acetyltransferase KAT2A | KAT2A | 11220 | nM | Potency |
TKC056482 | Q9F4F7 | 4'-phosphopantetheinyl transferase ffp | ffp | 56234 | nM | Potency |
TKC056482 | P06746 | DNA polymerase beta | POLB | 18600 | nM | IC50 |
TKC056482 | P10520 | Streptokinase A | ska | 1790 | nM | EC50 |
TKC056482 | P10586 | Receptor-type tyrosine-protein phosphatase F | PTPRF | >3800 | nM | IC50 |
TKC056482 | P10586 | Receptor-type tyrosine-protein phosphatase F | PTPRF | >40000 | nM | IC50 |
TKC056482 | P29350 | Tyrosine-protein phosphatase non-receptor type 6 | PTPN6 | 25780 | nM | IC50 |
TKC056482 | Q16665 | Hypoxia-inducible factor 1-alpha | HIF1A | >100000 | nM | IC50 |
TKC056482 | Q16665 | Hypoxia-inducible factor 1-alpha | HIF1A | >100000 | nM | IC50 |
TKC056482 | P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | HSD11B1 | 1900 | nM | IC50 |
TKC056482 | P51450 | Nuclear receptor ROR-gamma | Rorc | 499 | nM | Potency |
TKC056482 | O94925 | Glutaminase kidney isoform, mitochondrial | GLS | 17783 | nM | Potency |
TKC056482 | P05979 | Prostaglandin G/H synthase 1 | PTGS1 | >71 | % | Activity |
TKC056482 | P49841 | Glycogen synthase kinase-3 beta | GSK3B | 0 | Activity | |
TKC056482 | P06766 | DNA polymerase beta | Polb | 4800 | nM | IC50 |
TKC056482 | P30305 | M-phase inducer phosphatase 2 | CDC25B | 0 | IC50 | |
TKC056482 | P42345 | Serine/threonine-protein kinase mTOR | MTOR | 0 | Inhibition | |
TKC056482 | Q8MK44 | Diacylglycerol O-acyltransferase 1 | DGAT1 | 21 | % | Inhibition |
TKC056482 | Q9BGL2 | Lecithin retinol acyltransferase | LRAT | 28 | % | Inhibition |
TKC056482 | P51449 | Nuclear receptor ROR-gamma | RORC | 130 | nM | IC50 |
TKC056482 | Q8WZA2 | Rap guanine nucleotide exchange factor 4 | RAPGEF4 | 50119 | nM | Potency |
TKC056482 | O60218 | Aldo-keto reductase family 1 member B10 | AKR1B10 | 2000 | nM | Ki |
TKC056482 | P15121 | Aldo-keto reductase family 1 member B1 | AKR1B1 | 41000 | nM | IC50 |
TKC056482 | Q96RI1 | Bile acid receptor | NR1H4 | 0 | nM | EC50 |
TKC056482 | Q07869 | Peroxisome proliferator-activated receptor alpha | PPARA | 259 | % | Activity |
TKC056482 | Q9UBN7 | Histone deacetylase 6 | HDAC6 | 0 | Inhibition | |
TKC056482 | Q93009 | Ubiquitin carboxyl-terminal hydrolase 7 | USP7 | 7000 | nM | IC50 |
TKC056482 | Q13547 | Histone deacetylase 1 | HDAC1 | 0 | Inhibition | |
TKC056482 | P00690 | Pancreatic alpha-amylase | AMY2 | 22600 | nM | IC50 |
TKC056482 | Q6P7A9 | Lysosomal alpha-glucosidase | Gaa | <50 | % | Inhibition |
TKC056482 | P18858 | DNA ligase 1 | LIG1 | 120 | ug.mL-1 | IC50 |
TKC056482 | P09917 | Polyunsaturated fatty acid 5-lipoxygenase | ALOX5 | >64 | % | Activity |
TKC056482 | P56524 | Histone deacetylase 4 | HDAC4 | 0 | Inhibition | |
TKC056482 | Q9UQL6 | Histone deacetylase 5 | HDAC5 | 0 | Inhibition | |
TKC056482 | P10253 | Lysosomal alpha-glucosidase | GAA | 4 | ug.mL-1 | IC50 |
TKC056482 | P10253 | Lysosomal alpha-glucosidase | GAA | 4.4 | nM | IC50 |
TKC056482 | P05067 | Amyloid-beta precursor protein | APP | 0 | Inhibition | |
TKC056482 | P23469 | Receptor-type tyrosine-protein phosphatase epsilon | PTPRE | >40000 | nM | IC50 |
TKC056482 | P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | HSD11B2 | 0 | Activity | |
TKC056482 | P54646 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | PRKAA2 | 0 | Activity | |
TKC056482 | P00489 | Glycogen phosphorylase, muscle form | PYGM | 8913 | nM | IC50 |
TKC056482 | P00489 | Glycogen phosphorylase, muscle form | PYGM | 15300 | nM | IC50 |
TKC056482 | P00489 | Glycogen phosphorylase, muscle form | PYGM | 9000 | nM | IC50 |
TKC056482 | P47196 | RAC-alpha serine/threonine-protein kinase | Akt1 | 2 | FC | |
TKC056482 | P49840 | Glycogen synthase kinase-3 alpha | GSK3A | 2 | FC | |
TKC056482 | P08047 | Transcription factor Sp1 | SP1 | 0 | Activity | |
TKC056482 | Q8TDU6 | G-protein coupled bile acid receptor 1 | GPBAR1 | 1430 | nM | EC50 |
TKC056482 | Q9QUK6 | Toll-like receptor 4 | Tlr4 | 0 | Inhibition | |
TKC056482 | Q96T53 | Ghrelin O-acyltransferase | MBOAT4 | >100000 | nM | IC50 |
TKC056482 | P24666 | Low molecular weight phosphotyrosine protein phosphatase | ACP1 | 7200 | nM | IC50 |
TKC056482 | P05227 | Histidine-rich protein PFHRP-II | None | 20000000 | nM | IC50 |
TKC056482 | P07339 | Cathepsin D | CTSD | 18200 | nM | IC50 |
TKC056482 | P07339 | Cathepsin D | CTSD | 18200 | nM | IC50 |
TKC056482 | P09810 | Tryptophan 5-hydroxylase 1 | Tph1 | 7 | % | Inhibition |
TKC056482 | O15379 | Histone deacetylase 3 | HDAC3 | 0 | Inhibition | |
TKC056482 | P00599 | Basic phospholipase A2 1 | None | 2900 | nM | IC50 |
TKC056482 | P02699 | Rhodopsin | RHO | 0 | Activity | |
TKC056482 | P03452 | Hemagglutinin | HA | 46500 | nM | Kd |
TKC056482 | P12276 | Fatty acid synthase | FASN | 13100 | nM | IC50 |
TKC056482 | P18433 | Receptor-type tyrosine-protein phosphatase alpha | PTPRA | >40000 | nM | IC50 |
TKC056482 | P19357 | Solute carrier family 2, facilitated glucose transporter member 4 | Slc2a4 | 1 | FC | |
TKC056482 | P22513 | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | None | 25 | % | Inhibition |
TKC056482 | P43428 | Glucose-6-phosphatase catalytic subunit 1 | G6pc1 | 18 | % | Inhibition |
TKC056482 | P54840 | Glycogen [starch] synthase, liver | GYS2 | 2 | FC | |
TKC056482 | P59264 | Basic phospholipase A2 PLA-A | None | 2500 | nM | IC50 |
TKC056482 | Q76270 | Env polyprotein | HIV1 ENV | >100000 | nM | EC50 |
TKC056482 | Q7T3S7 | Acidic phospholipase A2 EC-I | None | 2300 | nM | IC50 |
TKC056482 | Q96K76 | Ubiquitin carboxyl-terminal hydrolase 47 | USP47 | 26000 | nM | IC50 |
TKC056482 | Q96KS0 | Prolyl hydroxylase EGLN2 | EGLN2 | >50000 | nM | EC50 |
TKC056482 | Q9GZT9 | Egl nine homolog 1 | EGLN1 | >50000 | nM | EC50 |
Uniport ID | Uniport Name | ICD-11 | Disease |
---|---|---|---|
P23219 | PGH1_HUMAN | ICD-11: 8A20 | disease |
P23219 | PGH1_HUMAN | ICD-11: GA10 | Endometriosis |
P23219 | PGH1_HUMAN | ICD-11: LA11 | anomaly |
P23219 | PGH1_HUMAN | ICD-11: GA34 | pain |
P23219 | PGH1_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P23219 | PGH1_HUMAN | ICD-11: DD72 | colitis |
P23219 | PGH1_HUMAN | ICD-11: 5B50-5B71 | deficiency |
P23219 | PGH1_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
P23219 | PGH1_HUMAN | ICD-11: MG30-MG3Z | Pain |
P23219 | PGH1_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P23219 | PGH1_HUMAN | ICD-11: FA20 | arthritis |
P23219 | PGH1_HUMAN | ICD-11: EA81 | dermatitis |
P23219 | PGH1_HUMAN | ICD-11: 1B10-1B12 | Tuberculosis |
P23219 | PGH1_HUMAN | ICD-11: DD71 | colitis |
P23219 | PGH1_HUMAN | ICD-11: FB53 | lesion |
P23219 | PGH1_HUMAN | ICD-11: FB56 | disorder |
P23219 | PGH1_HUMAN | ICD-11: 2B91 | cancer |
P23219 | PGH1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P23219 | PGH1_HUMAN | ICD-11: 4A42 | sclerosis |
P23219 | PGH1_HUMAN | ICD-11: 4A44 | Vasculitis |
P23219 | PGH1_HUMAN | ICD-11: 8A03 | disorder |
P23219 | PGH1_HUMAN | ICD-11: 8C70 | dystrophy |
P23219 | PGH1_HUMAN | ICD-11: 8C0Z | Neuropathy |
P23219 | PGH1_HUMAN | ICD-11: MG26 | Fever |
P23219 | PGH1_HUMAN | ICD-11: FA25 | Gout |
P23219 | PGH1_HUMAN | ICD-11: MB40 | disturbance |
P23219 | PGH1_HUMAN | ICD-11: 5A11 | mellitus |
P23219 | PGH1_HUMAN | ICD-11: 8E43 | disorder |
O43451 | MGA_HUMAN | ICD-11: 5A2Y | complication |
O43451 | MGA_HUMAN | ICD-11: BA00-BE2Z | disease |
O43451 | MGA_HUMAN | ICD-11: 5C51 | error |
O43451 | MGA_HUMAN | ICD-11: FB32-FB3Z | disorder |
O43451 | MGA_HUMAN | ICD-11: 1C60-1C62 | disease |
O43451 | MGA_HUMAN | ICD-11: 5A11 | mellitus |
O43451 | MGA_HUMAN | ICD-11: 1D2Z | fever |
O43451 | MGA_HUMAN | ICD-11: MA18 | sympton |
O75874 | IDHC_HUMAN | ICD-11: 2A60 | leukaemia |
O75874 | IDHC_HUMAN | ICD-11: 2C12 | cancer |
O75874 | IDHC_HUMAN | ICD-11: 2B33 | neoplasm |
O75874 | IDHC_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
O75874 | IDHC_HUMAN | ICD-11: 2A60 | leukaemia |
O75874 | IDHC_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P19838 | NFKB1_HUMAN | ICD-11: 8C70 | dystrophy |
P19838 | NFKB1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P19838 | NFKB1_HUMAN | ICD-11: 5A11 | mellitus |
P27695 | APEX1_HUMAN | ICD-11: 9B71 | Retinopathy |
P27695 | APEX1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P27695 | APEX1_HUMAN | ICD-11: 2D00-2D07 | cancer |
P27695 | APEX1_HUMAN | ICD-11: 2A00 | cancer |
P27695 | APEX1_HUMAN | ICD-11: 2C30 | Melanoma |
P11511 | CP19A_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P11511 | CP19A_HUMAN | ICD-11: 5A70 | syndrome |
P11511 | CP19A_HUMAN | ICD-11: DA24 | Oesophagitis |
P11511 | CP19A_HUMAN | ICD-11: GA10 | Endometriosis |
P11511 | CP19A_HUMAN | ICD-11: 8C0Z | Neuropathy |
P11511 | CP19A_HUMAN | ICD-11: 2C94 | cancer |
P11511 | CP19A_HUMAN | ICD-11: GA91 | disease |
P11597 | CETP_HUMAN | ICD-11: BD40 | disease |
P11597 | CETP_HUMAN | ICD-11: BA00-BE2Z | disease |
P11597 | CETP_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P11597 | CETP_HUMAN | ICD-11: BA41-BA43 | infarction |
P11597 | CETP_HUMAN | ICD-11: 5C52 | error |
P11597 | CETP_HUMAN | ICD-11: BD4Z | disease |
P11597 | CETP_HUMAN | ICD-11: 5C80-5C81 | Dyslipidemia |
P08246 | ELNE_HUMAN | ICD-11: NB32 | injury |
P08246 | ELNE_HUMAN | ICD-11: CA40 | Pneumonia |
P08246 | ELNE_HUMAN | ICD-11: 9A96 | uveitis |
P08246 | ELNE_HUMAN | ICD-11: DD70 | disease |
P08246 | ELNE_HUMAN | ICD-11: DB93 | fibrosis/cirrhosis |
P08246 | ELNE_HUMAN | ICD-11: FA92 | spondyloarthritis |
P08246 | ELNE_HUMAN | ICD-11: 8A40 | sclerosis |
P08246 | ELNE_HUMAN | ICD-11: FA21 | arthritis |
P08246 | ELNE_HUMAN | ICD-11: EB21 | gangrenosum |
P08246 | ELNE_HUMAN | ICD-11: FA20 | arthritis |
P08246 | ELNE_HUMAN | ICD-11: DD71 | colitis |
P08246 | ELNE_HUMAN | ICD-11: CA24 | Bronchiectasis |
P08246 | ELNE_HUMAN | ICD-11: CA22 | disease |
P08246 | ELNE_HUMAN | ICD-11: CA25 | fibrosis |
P08246 | ELNE_HUMAN | ICD-11: BA41-BA43 | infarction |
P08246 | ELNE_HUMAN | ICD-11: SA80-SA8Z | cough |
P08246 | ELNE_HUMAN | ICD-11: EA80 | eczema |
P08246 | ELNE_HUMAN | ICD-11: CA21 | Emphysema |
P08246 | ELNE_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P08246 | ELNE_HUMAN | ICD-11: CB00 | syndrome |
P08246 | ELNE_HUMAN | ICD-11: NA00-ND5Z | Injury |
P08246 | ELNE_HUMAN | ICD-11: 1B10-1F85 | disease |
P08246 | ELNE_HUMAN | ICD-11: 1G40-1G41 | Sepsis |
P35354 | PGH2_HUMAN | ICD-11: 8A20 | disease |
P35354 | PGH2_HUMAN | ICD-11: MG30 | pain |
P35354 | PGH2_HUMAN | ICD-11: GA10 | Endometriosis |
P35354 | PGH2_HUMAN | ICD-11: GA34 | pain |
P35354 | PGH2_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P35354 | PGH2_HUMAN | ICD-11: DD72 | colitis |
P35354 | PGH2_HUMAN | ICD-11: FA01 | osteoarthritis |
P35354 | PGH2_HUMAN | ICD-11: 8A80 | Migraine |
P35354 | PGH2_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
P35354 | PGH2_HUMAN | ICD-11: MG30-MG3Z | Pain |
P35354 | PGH2_HUMAN | ICD-11: FA20 | arthritis |
P35354 | PGH2_HUMAN | ICD-11: 1B10-1B12 | Tuberculosis |
P35354 | PGH2_HUMAN | ICD-11: FB53 | lesion |
P35354 | PGH2_HUMAN | ICD-11: FB56 | disorder |
P35354 | PGH2_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P35354 | PGH2_HUMAN | ICD-11: CA23 | Asthma |
P35354 | PGH2_HUMAN | ICD-11: FA25 | Gout |
P35354 | PGH2_HUMAN | ICD-11: 8E43 | disorder |
P35354 | PGH2_HUMAN | ICD-11: 4A40 | erythematosus |
P35354 | PGH2_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P35354 | PGH2_HUMAN | ICD-11: DB35 | polyp |
P35354 | PGH2_HUMAN | ICD-11: 2C25 | cancer |
P35354 | PGH2_HUMAN | ICD-11: 2C10 | cancer |
P35354 | PGH2_HUMAN | ICD-11: 5A11 | mellitus |
P35354 | PGH2_HUMAN | ICD-11: 2B91 | cancer |
P35354 | PGH2_HUMAN | ICD-11: MG26 | Fever |
P35354 | PGH2_HUMAN | ICD-11: 2B33 | neoplasm |
P35354 | PGH2_HUMAN | ICD-11: 8A20 | disease |
P35354 | PGH2_HUMAN | ICD-11: MG30 | pain |
P35354 | PGH2_HUMAN | ICD-11: GA10 | Endometriosis |
P35354 | PGH2_HUMAN | ICD-11: GA34 | pain |
P35354 | PGH2_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P35354 | PGH2_HUMAN | ICD-11: DD72 | colitis |
P35354 | PGH2_HUMAN | ICD-11: FA01 | osteoarthritis |
P35354 | PGH2_HUMAN | ICD-11: 8A80 | Migraine |
P35354 | PGH2_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
P35354 | PGH2_HUMAN | ICD-11: MG30-MG3Z | Pain |
P35354 | PGH2_HUMAN | ICD-11: FA20 | arthritis |
P35354 | PGH2_HUMAN | ICD-11: 1B10-1B12 | Tuberculosis |
P35354 | PGH2_HUMAN | ICD-11: FB53 | lesion |
P35354 | PGH2_HUMAN | ICD-11: FB56 | disorder |
P35354 | PGH2_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P35354 | PGH2_HUMAN | ICD-11: CA23 | Asthma |
P35354 | PGH2_HUMAN | ICD-11: FA25 | Gout |
P35354 | PGH2_HUMAN | ICD-11: 8E43 | disorder |
P35354 | PGH2_HUMAN | ICD-11: 4A40 | erythematosus |
P35354 | PGH2_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P35354 | PGH2_HUMAN | ICD-11: DB35 | polyp |
P35354 | PGH2_HUMAN | ICD-11: 2C25 | cancer |
P35354 | PGH2_HUMAN | ICD-11: 2C10 | cancer |
P35354 | PGH2_HUMAN | ICD-11: 5A11 | mellitus |
P35354 | PGH2_HUMAN | ICD-11: 2B91 | cancer |
P35354 | PGH2_HUMAN | ICD-11: MG26 | Fever |
P35354 | PGH2_HUMAN | ICD-11: 2B33 | neoplasm |
P35354 | PGH2_HUMAN | ICD-11: 8A20 | disease |
P35354 | PGH2_HUMAN | ICD-11: MG30 | pain |
P35354 | PGH2_HUMAN | ICD-11: GA10 | Endometriosis |
P35354 | PGH2_HUMAN | ICD-11: GA34 | pain |
P35354 | PGH2_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P35354 | PGH2_HUMAN | ICD-11: DD72 | colitis |
P35354 | PGH2_HUMAN | ICD-11: FA01 | osteoarthritis |
P35354 | PGH2_HUMAN | ICD-11: 8A80 | Migraine |
P35354 | PGH2_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
P35354 | PGH2_HUMAN | ICD-11: MG30-MG3Z | Pain |
P35354 | PGH2_HUMAN | ICD-11: FA20 | arthritis |
P35354 | PGH2_HUMAN | ICD-11: 1B10-1B12 | Tuberculosis |
P35354 | PGH2_HUMAN | ICD-11: FB53 | lesion |
P35354 | PGH2_HUMAN | ICD-11: FB56 | disorder |
P35354 | PGH2_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P35354 | PGH2_HUMAN | ICD-11: CA23 | Asthma |
P35354 | PGH2_HUMAN | ICD-11: FA25 | Gout |
P35354 | PGH2_HUMAN | ICD-11: 8E43 | disorder |
P35354 | PGH2_HUMAN | ICD-11: 4A40 | erythematosus |
P35354 | PGH2_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P35354 | PGH2_HUMAN | ICD-11: DB35 | polyp |
P35354 | PGH2_HUMAN | ICD-11: 2C25 | cancer |
P35354 | PGH2_HUMAN | ICD-11: 2C10 | cancer |
P35354 | PGH2_HUMAN | ICD-11: 5A11 | mellitus |
P35354 | PGH2_HUMAN | ICD-11: 2B91 | cancer |
P35354 | PGH2_HUMAN | ICD-11: MG26 | Fever |
P35354 | PGH2_HUMAN | ICD-11: 2B33 | neoplasm |
P06746 | DPOLB_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q16665 | HIF1A_HUMAN | ICD-11: 5A75 | hyperfunction |
Q16665 | HIF1A_HUMAN | ICD-11: 2A00 | cancer |
Q16665 | HIF1A_HUMAN | ICD-11: 2A80-2A86 | Lymphoma |
Q16665 | HIF1A_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q16665 | HIF1A_HUMAN | ICD-11: BB01 | hypertension |
Q16665 | HIF1A_HUMAN | ICD-11: 5A75 | hyperfunction |
Q16665 | HIF1A_HUMAN | ICD-11: 2A00 | cancer |
Q16665 | HIF1A_HUMAN | ICD-11: 2A80-2A86 | Lymphoma |
Q16665 | HIF1A_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q16665 | HIF1A_HUMAN | ICD-11: BB01 | hypertension |
P28845 | DHI1_HUMAN | ICD-11: 1E30-1E32 | Influenza |
P28845 | DHI1_HUMAN | ICD-11: 4A40 | erythematosus |
P28845 | DHI1_HUMAN | ICD-11: 8C6Y | gravis |
P28845 | DHI1_HUMAN | ICD-11: 5A11 | mellitus |
P28845 | DHI1_HUMAN | ICD-11: 5A2Y | complication |
P28845 | DHI1_HUMAN | ICD-11: 8A20 | disease |
P28845 | DHI1_HUMAN | ICD-11: 9C61 | Glaucoma |
P28845 | DHI1_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P28845 | DHI1_HUMAN | ICD-11: 5C50-5D2Z | disorder |
P28845 | DHI1_HUMAN | ICD-11: 5C52 | error |
P28845 | DHI1_HUMAN | ICD-11: 5B80-5B81 | Obesity |
P49841 | GSK3B_HUMAN | ICD-11: 8C71 | disorder |
P49841 | GSK3B_HUMAN | ICD-11: 2A60 | leukaemia |
P49841 | GSK3B_HUMAN | ICD-11: LD55 | chromosome |
P49841 | GSK3B_HUMAN | ICD-11: 2A20 | neoplasm |
P49841 | GSK3B_HUMAN | ICD-11: 2B51 | Osteosarcoma |
P49841 | GSK3B_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P49841 | GSK3B_HUMAN | ICD-11: 8A00 | Parkinsonism |
P49841 | GSK3B_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P49841 | GSK3B_HUMAN | ICD-11: 2A00 | cancer |
P49841 | GSK3B_HUMAN | ICD-11: 2C73 | cancer |
P49841 | GSK3B_HUMAN | ICD-11: NE84 | rejection |
P49841 | GSK3B_HUMAN | ICD-11: 8A20 | disease |
P49841 | GSK3B_HUMAN | ICD-11: 5A2Y | complication |
P30305 | MPIP2_HUMAN | ICD-11: 2C25 | cancer |
P30305 | MPIP2_HUMAN | ICD-11: 2B6B | cancer |
P30305 | MPIP2_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P42345 | MTOR_HUMAN | ICD-11: BD52 | disorder |
P42345 | MTOR_HUMAN | ICD-11: 2A40 | leukaemia |
P42345 | MTOR_HUMAN | ICD-11: 8D64 | Hydrocephalus |
P42345 | MTOR_HUMAN | ICD-11: 2A83 | myeloma |
P42345 | MTOR_HUMAN | ICD-11: 2C90 | carcinoma |
P42345 | MTOR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P42345 | MTOR_HUMAN | ICD-11: NE84 | rejection |
P42345 | MTOR_HUMAN | ICD-11: 2A60-2C35 | Sarcoma |
P42345 | MTOR_HUMAN | ICD-11: 2C94 | cancer |
P42345 | MTOR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P42345 | MTOR_HUMAN | ICD-11: 2C76 | cancer |
P42345 | MTOR_HUMAN | ICD-11: 2D42 | cancer |
P42345 | MTOR_HUMAN | ICD-11: 2C12 | cancer |
P42345 | MTOR_HUMAN | ICD-11: 2C25 | cancer |
P42345 | MTOR_HUMAN | ICD-11: 2B33 | neoplasm |
P42345 | MTOR_HUMAN | ICD-11: 2B5D-2B5Y | neoplasm |
P42345 | MTOR_HUMAN | ICD-11: 2D60 | neoplasm |
P42345 | MTOR_HUMAN | ICD-11: MG30-MG3Z | Pain |
P42345 | MTOR_HUMAN | ICD-11: 2C10 | cancer |
P42345 | MTOR_HUMAN | ICD-11: 2C82 | cancer |
P42345 | MTOR_HUMAN | ICD-11: BB01 | hypertension |
P42345 | MTOR_HUMAN | ICD-11: CB07 | Lymphangioleiomyomatosis |
P42345 | MTOR_HUMAN | ICD-11: 2A80-2A86 | Lymphoma |
P42345 | MTOR_HUMAN | ICD-11: 2C26 | mesothelioma |
P42345 | MTOR_HUMAN | ICD-11: 2A90 | lymphoma |
P42345 | MTOR_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P42345 | MTOR_HUMAN | ICD-11: DD71 | colitis |
P51449 | RORG_HUMAN | ICD-11: 4A40-4A45 | disease |
P51449 | RORG_HUMAN | ICD-11: 2C25 | cancer |
P51449 | RORG_HUMAN | ICD-11: EA90 | Psoriasis |
P51449 | RORG_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P51449 | RORG_HUMAN | ICD-11: DD70 | disease |
P51449 | RORG_HUMAN | ICD-11: 8A40 | sclerosis |
P51449 | RORG_HUMAN | ICD-11: BD40 | disease |
P51449 | RORG_HUMAN | ICD-11: 2C12 | cancer |
P51449 | RORG_HUMAN | ICD-11: FA20 | arthritis |
P15121 | ALDR_HUMAN | ICD-11: 8C0Z | Neuropathy |
P15121 | ALDR_HUMAN | ICD-11: MG30-MG3Z | Pain |
P15121 | ALDR_HUMAN | ICD-11: FA20 | arthritis |
P15121 | ALDR_HUMAN | ICD-11: 5A2Y | complication |
P15121 | ALDR_HUMAN | ICD-11: DB61-GB90 | Thrombosis |
P15121 | ALDR_HUMAN | ICD-11: 9B10 | Cataract |
P15121 | ALDR_HUMAN | ICD-11: 9C61 | Glaucoma |
P15121 | ALDR_HUMAN | ICD-11: 6A20 | Schizophrenia |
P15121 | ALDR_HUMAN | ICD-11: FA25 | Gout |
P15121 | ALDR_HUMAN | ICD-11: 2D42 | cancer |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB96 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: DC11 | Cholelithiasis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 7A00-7A0Z | Insomnia |
Q96RI1 | NR1H4_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 2C60-2C6Y | cancer |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB92 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: GB61 | disease |
Q96RI1 | NR1H4_HUMAN | ICD-11: LD24 | anomaly |
Q96RI1 | NR1H4_HUMAN | ICD-11: DB93 | fibrosis/cirrhosis |
Q96RI1 | NR1H4_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q96RI1 | NR1H4_HUMAN | ICD-11: 5A11 | mellitus |
Q07869 | PPARA_HUMAN | ICD-11: BA00-BE2Z | disease |
Q07869 | PPARA_HUMAN | ICD-11: 5C80 | Hyperlipidemia |
Q07869 | PPARA_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q07869 | PPARA_HUMAN | ICD-11: 5C52 | error |
Q07869 | PPARA_HUMAN | ICD-11: 5A11 | mellitus |
Q07869 | PPARA_HUMAN | ICD-11: 5A10 | mellitus |
Q07869 | PPARA_HUMAN | ICD-11: DB92 | disease |
Q07869 | PPARA_HUMAN | ICD-11: 5A2Y | complication |
Q07869 | PPARA_HUMAN | ICD-11: 5C80-5C81 | Dyslipidemia |
Q07869 | PPARA_HUMAN | ICD-11: FA25 | Gout |
Q07869 | PPARA_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q07869 | PPARA_HUMAN | ICD-11: BD10-BD1Z | failure |
Q07869 | PPARA_HUMAN | ICD-11: BD40 | disease |
Q07869 | PPARA_HUMAN | ICD-11: CB03 | pneumonitis |
Q07869 | PPARA_HUMAN | ICD-11: 5C50-5D2Z | disorder |
Q07869 | PPARA_HUMAN | ICD-11: FA20 | arthritis |
Q9UBN7 | HDAC6_HUMAN | ICD-11: 2A83 | myeloma |
Q9UBN7 | HDAC6_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q13547 | HDAC1_HUMAN | ICD-11: 2A90 | lymphoma |
Q13547 | HDAC1_HUMAN | ICD-11: 2A83 | myeloma |
Q13547 | HDAC1_HUMAN | ICD-11: 2B01 | fungoides |
Q13547 | HDAC1_HUMAN | ICD-11: 2A20 | neoplasm |
Q13547 | HDAC1_HUMAN | ICD-11: 2C90 | carcinoma |
Q13547 | HDAC1_HUMAN | ICD-11: 5A11 | mellitus |
Q13547 | HDAC1_HUMAN | ICD-11: 2C25 | cancer |
Q13547 | HDAC1_HUMAN | ICD-11: 2C30 | Melanoma |
Q13547 | HDAC1_HUMAN | ICD-11: 2C34 | carcinoma |
Q13547 | HDAC1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q13547 | HDAC1_HUMAN | ICD-11: 2C60-2C6Y | cancer |
Q13547 | HDAC1_HUMAN | ICD-11: 2B91 | cancer |
Q13547 | HDAC1_HUMAN | ICD-11: 2A60-2B33 | Leukaemia |
Q13547 | HDAC1_HUMAN | ICD-11: 6A60-6E23 | disorder |
Q13547 | HDAC1_HUMAN | ICD-11: 8C70 | dystrophy |
Q13547 | HDAC1_HUMAN | ICD-11: 2C73 | cancer |
Q13547 | HDAC1_HUMAN | ICD-11: 3B63 | Thrombocytosis |
Q13547 | HDAC1_HUMAN | ICD-11: 2A60 | leukaemia |
Q13547 | HDAC1_HUMAN | ICD-11: 8B1Z | ischaemia |
Q13547 | HDAC1_HUMAN | ICD-11: 8B11 | stroke |
Q13547 | HDAC1_HUMAN | ICD-11: 2A81 | lymphoma |
Q13547 | HDAC1_HUMAN | ICD-11: NA07 | injury |
Q13547 | HDAC1_HUMAN | ICD-11: 8B20 | stroke |
Q13547 | HDAC1_HUMAN | ICD-11: 2C12 | cancer |
Q13547 | HDAC1_HUMAN | ICD-11: 5C50 | error |
Q13547 | HDAC1_HUMAN | ICD-11: 3A51 | disorder |
Q13547 | HDAC1_HUMAN | ICD-11: 2A80-2A86 | Lymphoma |
Q13547 | HDAC1_HUMAN | ICD-11: 8A03 | disorder |
P09917 | LOX5_HUMAN | ICD-11: CA23 | Asthma |
P09917 | LOX5_HUMAN | ICD-11: 1F66 | Filariasis |
P09917 | LOX5_HUMAN | ICD-11: 3B64 | Thrombocytopenia |
P09917 | LOX5_HUMAN | ICD-11: 2C25 | cancer |
P09917 | LOX5_HUMAN | ICD-11: 2B6B | cancer |
P09917 | LOX5_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P09917 | LOX5_HUMAN | ICD-11: FA20 | arthritis |
P09917 | LOX5_HUMAN | ICD-11: EA80 | eczema |
P09917 | LOX5_HUMAN | ICD-11: 5B10 | syndrome |
P09917 | LOX5_HUMAN | ICD-11: 1F29-1F2F | infection |
P09917 | LOX5_HUMAN | ICD-11: CB03 | pneumonitis |
P09917 | LOX5_HUMAN | ICD-11: 1E30-1E32 | Influenza |
P09917 | LOX5_HUMAN | ICD-11: 5A60-5A61 | disorder |
P09917 | LOX5_HUMAN | ICD-11: EA90 | Psoriasis |
P09917 | LOX5_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P09917 | LOX5_HUMAN | ICD-11: MG30-MG3Z | Pain |
P09917 | LOX5_HUMAN | ICD-11: CB40-CB7Z | disease |
P09917 | LOX5_HUMAN | ICD-11: BA00-BE2Z | disease |
P09917 | LOX5_HUMAN | ICD-11: CA22 | disease |
P09917 | LOX5_HUMAN | ICD-11: EA80-EA89 | Eczema |
P09917 | LOX5_HUMAN | ICD-11: EC90 | Pruritus |
P09917 | LOX5_HUMAN | ICD-11: DB61-GB90 | Thrombosis |
P09917 | LOX5_HUMAN | ICD-11: FA00-FA05 | Osteoarthritis |
P09917 | LOX5_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P09917 | LOX5_HUMAN | ICD-11: BD40 | disease |
P09917 | LOX5_HUMAN | ICD-11: 1F40-1F45 | Malaria |
P09917 | LOX5_HUMAN | ICD-11: CA23 | Asthma |
P09917 | LOX5_HUMAN | ICD-11: MG30-MG3Z | Pain |
P09917 | LOX5_HUMAN | ICD-11: FA20 | arthritis |
P56524 | HDAC4_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P10253 | LYAG_HUMAN | ICD-11: 5C51 | error |
P10253 | LYAG_HUMAN | ICD-11: 5C51 | error |
P05067 | A4_HUMAN | ICD-11: N.A. | imaging |
P05067 | A4_HUMAN | ICD-11: 8A20 | disease |
P05067 | A4_HUMAN | ICD-11: 2F7C | tumour |
P05067 | A4_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P05067 | A4_HUMAN | ICD-11: 9B71 | Retinopathy |
P05067 | A4_HUMAN | ICD-11: EC32 | bullosa |
P05067 | A4_HUMAN | ICD-11: 5D00 | Amyloidosis |
P05067 | A4_HUMAN | ICD-11: 9B75 | degeneration |
P05067 | A4_HUMAN | ICD-11: NA07 | injury |
P05067 | A4_HUMAN | ICD-11: 2A00 | cancer |
P05067 | A4_HUMAN | ICD-11: 6B60 | disorder |
P05067 | A4_HUMAN | ICD-11: 6D71 | disorder |
P80365 | DHI2_HUMAN | ICD-11: 5A11 | mellitus |
P49840 | GSK3A_HUMAN | ICD-11: 8A61-8A6Z | Epilepsy/seizure |
P49840 | GSK3A_HUMAN | ICD-11: 6C40 | abuse |
P49840 | GSK3A_HUMAN | ICD-11: 2A60 | leukaemia |
P49840 | GSK3A_HUMAN | ICD-11: LD55 | chromosome |
P49840 | GSK3A_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P49840 | GSK3A_HUMAN | ICD-11: 2A00 | cancer |
P49840 | GSK3A_HUMAN | ICD-11: 2C73 | cancer |
P49840 | GSK3A_HUMAN | ICD-11: NE84 | rejection |
P08047 | SP1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
Q8TDU6 | GPBAR_HUMAN | ICD-11: 5A11 | mellitus |
Q8TDU6 | GPBAR_HUMAN | ICD-11: DB93 | fibrosis/cirrhosis |
Q8TDU6 | GPBAR_HUMAN | ICD-11: 5C50-5D2Z | disorder |
Q96T53 | MBOA4_HUMAN | ICD-11: 5B80-5B81 | Obesity |
Q96T53 | MBOA4_HUMAN | ICD-11: 5A11 | mellitus |
P07339 | CATD_HUMAN | ICD-11: 8A40 | sclerosis |
P07339 | CATD_HUMAN | ICD-11: BA00-BA04 | Hypertension |
P07339 | CATD_HUMAN | ICD-11: 8A40 | sclerosis |
P07339 | CATD_HUMAN | ICD-11: BA00-BA04 | Hypertension |
O15379 | HDAC3_HUMAN | ICD-11: 2A80-2A86 | Lymphoma |
O15379 | HDAC3_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P03452 | HEMA_I34A1 | ICD-11: 1A24-1D9Z | infection |
P03452 | HEMA_I34A1 | ICD-11: 1E30-1E32 | Influenza |
P03452 | HEMA_I34A1 | ICD-11: 1A00-CA43 | inflammation |
Q96KS0 | EGLN2_HUMAN | ICD-11: 3A90 | anaemia |
Q96KS0 | EGLN2_HUMAN | ICD-11: 6A02 | disorder |
Q96KS0 | EGLN2_HUMAN | ICD-11: BD54 | ulcer |
Q96KS0 | EGLN2_HUMAN | ICD-11: GC2Z | disease |
Q96KS0 | EGLN2_HUMAN | ICD-11: 3A00-3A9Z | Anemia |
Q9GZT9 | EGLN1_HUMAN | ICD-11: 3A90 | anaemia |
Q9GZT9 | EGLN1_HUMAN | ICD-11: GC2Z | disease |
Q9GZT9 | EGLN1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |